232 related articles for article (PubMed ID: 25113789)
1. The evolution of primary progressive apraxia of speech.
Josephs KA; Duffy JR; Strand EA; Machulda MM; Senjem ML; Gunter JL; Schwarz CG; Reid RI; Spychalla AJ; Lowe VJ; Jack CR; Whitwell JL
Brain; 2014 Oct; 137(Pt 10):2783-95. PubMed ID: 25113789
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia.
Tetzloff KA; Duffy JR; Clark HM; Strand EA; Machulda MM; Schwarz CG; Senjem ML; Reid RI; Spychalla AJ; Tosakulwong N; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
Brain; 2018 Jan; 141(1):302-317. PubMed ID: 29228180
[TBL] [Abstract][Full Text] [Related]
3. Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy.
Sintini I; Kaufman K; Botha H; Martin PR; Loushin SR; Senjem ML; Reid RI; Schwarz CG; Jack CR; Lowe VJ; Josephs KA; Whitwell JL; Ali F
Neuroimage Clin; 2021; 32():102850. PubMed ID: 34655905
[TBL] [Abstract][Full Text] [Related]
4. Multimodal cross-examination of progressive apraxia of speech by diffusion tensor imaging-based tractography and Tau-PET scans.
Gatto RG; Pham NTT; Duffy JR; Clark HM; Utianski RL; Botha H; Machulda MM; Lowe VJ; Schwarz CG; Jack CR; Josephs KA; Whitwell JL
Hum Brain Mapp; 2024 Jun; 45(8):e26704. PubMed ID: 38825988
[TBL] [Abstract][Full Text] [Related]
5. Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech.
Botha H; Duffy JR; Whitwell JL; Strand EA; Machulda MM; Schwarz CG; Reid RI; Spychalla AJ; Senjem ML; Jones DT; Lowe V; Jack CR; Josephs KA
Cortex; 2015 Aug; 69():220-36. PubMed ID: 26103600
[TBL] [Abstract][Full Text] [Related]
6. Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants.
Orlandi F; Carlos AF; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Stephens YC; Schwarz CG; Senjem ML; Jack CR; Agosta F; Filippi M; Dickson DW; Josephs KA; Whitwell JL
Brain Commun; 2024; 6(2):fcae113. PubMed ID: 38660629
[TBL] [Abstract][Full Text] [Related]
7. Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis.
Rohrer JD; Paviour D; Bronstein AM; O'Sullivan SS; Lees A; Warren JD
Mov Disord; 2010 Jan; 25(2):179-188. PubMed ID: 20077483
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal flortaucipir, metabolism and volume differ between phonetic and prosodic speech apraxia.
Tetzloff KA; Martin PR; Duffy JR; Utianski RL; Clark HM; Botha H; Machulda MM; Thu Pham NT; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Brain; 2024 May; 147(5):1696-1709. PubMed ID: 38217867
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.
Josephs KA; Duffy JR; Strand EA; Whitwell JL; Layton KF; Parisi JE; Hauser MF; Witte RJ; Boeve BF; Knopman DS; Dickson DW; Jack CR; Petersen RC
Brain; 2006 Jun; 129(Pt 6):1385-98. PubMed ID: 16613895
[TBL] [Abstract][Full Text] [Related]
10. The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.
Spina S; Farlow MR; Unverzagt FW; Kareken DA; Murrell JR; Fraser G; Epperson F; Crowther RA; Spillantini MG; Goedert M; Ghetti B
Brain; 2008 Jan; 131(Pt 1):72-89. PubMed ID: 18065436
[TBL] [Abstract][Full Text] [Related]
11. A case of atypical progressive supranuclear palsy.
Spaccavento S; Del Prete M; Craca A; Loverre A
Clin Interv Aging; 2014; 9():31-9. PubMed ID: 24368882
[TBL] [Abstract][Full Text] [Related]
12. Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy.
Brown JA; Hua AY; Trujllo A; Attygalle S; Binney RJ; Spina S; Lee SE; Kramer JH; Miller BL; Rosen HJ; Boxer AL; Seeley WW
Neuroimage Clin; 2017; 16():564-574. PubMed ID: 28951832
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological associations of hemispheric dominance in primary progressive apraxia of speech.
Robinson CG; Duffy JR; Clark HA; Utianski RL; Machulda MM; Botha H; Singh NA; Pham NTT; Ertekin-Taner N; Dickson DW; Lowe VJ; Whitwell JL; Josephs KA
Eur J Neurol; 2023 May; 30(5):1209-1219. PubMed ID: 36869612
[TBL] [Abstract][Full Text] [Related]
14. Non-right handed primary progressive apraxia of speech.
Botha H; Duffy JR; Whitwell JL; Strand EA; Machulda MM; Spychalla AJ; Tosakulwong N; Senjem ML; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
J Neurol Sci; 2018 Jul; 390():246-254. PubMed ID: 29801898
[TBL] [Abstract][Full Text] [Related]
15. Loss of Mickey Mouse Ears' Sign in Progressive Supranuclear Palsy.
Chow TK; Ma KM
Clin Nucl Med; 2024 Jun; 49(6):551-553. PubMed ID: 38598736
[TBL] [Abstract][Full Text] [Related]
16. An Update on Apraxia of Speech.
Utianski RL; Josephs KA
Curr Neurol Neurosci Rep; 2023 Jul; 23(7):353-359. PubMed ID: 37269450
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal clinical decline and baseline predictors in progressive supranuclear palsy.
Pavone C; Weigand SW; Ali F; Clark HM; Botha H; Machulda MM; Savica R; Pham NTT; Grijalva RM; Schwarz CG; Senjem ML; Agosta F; Filippi M; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Parkinsonism Relat Disord; 2023 Feb; 107():105290. PubMed ID: 36682219
[TBL] [Abstract][Full Text] [Related]
18. Progression to corticobasal syndrome: a longitudinal study of patients with nonfluent primary progressive aphasia and primary progressive apraxia of speech.
Garcia-Guaqueta DP; Botha H; Utianski RL; Duffy JR; Clark HM; Goodrich AW; Pham NTT; Machulda MM; Baker M; Rademakers R; Whitwell JL; Josephs KA
J Neurol; 2024 Apr; ():. PubMed ID: 38583104
[TBL] [Abstract][Full Text] [Related]
19. Language impairment in progressive supranuclear palsy and corticobasal syndrome.
Peterson KA; Patterson K; Rowe JB
J Neurol; 2021 Mar; 268(3):796-809. PubMed ID: 31321513
[TBL] [Abstract][Full Text] [Related]
20. Primary Progressive Apraxia of Speech: From Recognition to Diagnosis and Care.
Duffy JR; Utianski RL; Josephs KA
Aphasiology; 2021; 35(4):560-591. PubMed ID: 34219857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
